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Introduction: Intensive care unit-acquired weakness (ICU-AW) is common in survivors of critical illness, resulting in
global weakness and functional deficit. Although ICU-AW is well described subjectively in the literature, the value of
objective measures has yet to be established. This project aimed to evaluate the construct validity of the Chelsea
Critical Care Physical Assessment tool (CPAx) by analyzing the association between CPAx scores and hospital-discharge
location, as a measure of functional outcome.
Methods: The CPAx was integrated into practice as a service-improvement initiative in an 11-bed intensive care unit
(ICU). For patients admitted for more than 48 hours, between 10 May 2010 and 13 November 2013, the last CPAx score
within 24 hours of step down from the ICU or death was recorded (n = 499). At hospital discharge, patients were
separated into seven categories, based on continued rehabilitation and care needs. Descriptive statistics were
used to explore the association between ICU discharge CPAx score and hospital-discharge location.
Results: Of the 499 patients, 171 (34.3%) returned home with no ongoing rehabilitation or care input; 131 (26.2%)
required community support; 28 (5.6%) went to inpatient rehabilitation for <6 weeks; and 25 (5.0%) went to inpatient
rehabilitation for >6 weeks; 27 (5.4%) required nursing home level of care; 80 (16.0%) died in the ICU, and 37 (7.4%)
died in hospital. A significant difference was found in the median CPAx score between groups (P < 0.0001). Four
patients (0.8%) scored full marks (50) on the CPAx, all of whom went home with no ongoing needs; 16 patients (3.2%)
scored 0 on the CPAx, all of whom died within 24 hours. A 0.8% ceiling effect and a 3.2% floor effect of the CPAx is
found in the ICU. Compliance with completion of the CPAx stabilized at 78% of all ICU admissions.
Conclusion: The CPAx score at ICU discharge has displayed construct validity by crudely discriminating between
groups with different functional needs at hospital discharge. The CPAx has a limited floor and ceiling effect in survivors
of critical illness. A significant proportion of patients had a requirement for postdischarge care and rehabilitation.Introduction
For many, critical illness is catastrophic and, even for
survivors, can be life changing. Multiorgan failure, along
with its associated immobility and inflammatory state,
leads to rapid and significant muscle loss, which can
reach up to 15% within 7 days [1,2]. This is due to a reduc-
tion in protein synthesis and increased protein breakdown,
as well as myofibril necrosis [1].* Correspondence: e.corner13@imperial.ac.uk
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unless otherwise stated.These pathophysiologic changes lead to measurable
impairment of muscle strength associated with disability
and functional decline, often coupled with a reduction
in health-related quality of life [3]. This syndrome is
commonly known as Intensive Care Unit-Acquired Weak-
ness (ICU-AW). Research has shown that ICU-AW affects
anywhere between 25% and 100% of critically ill patients
[3]. With around 110,000 patients admitted to ICUs in
England and Wales annually, this public health issue that
extends well beyond the walls of the ICU [4,5], and we
have no reason to conclude that this would be different in
other countries.
The development of measurement tools has paved the
way to facilitate both communication of patient descriptionLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tation from critical illness, despite the obvious importance
of identifying interventions so that recovery can be opti-
mized, an incomplete development of tools has occurred
to measure and describe levels of functional impairment
[6,7]; still lacking is a simple means of measuring func-
tional recovery from critical illness that can be used both
to facilitate communication and as a potential outcome
measure.
Of the measurement systems currently available for the
assessment of ICU-AW, The Medical Research Council
(MRC) sumscore has been commonly used [8,9]. This is
an impairment-specific volitional test that involves the
manual grading of strength in 12 muscle groups. However,
the volitional nature of the MRC sumscore requires the
patient to be cooperative, which is frequently problematic
in the ICU cohort. Additionally, some components of
the MRC score are subjective, and predictive validity for
hospital length of stay and mortality is modest [10,11].
In the analysis of ICU-AW, it may be more appropriate
to use a functional measure instead of an impairment-
specific tool, as function is a manifestation of a number of
different qualities, such as strength, cognition, alertness,
balance, and so on. Hence using a functional measure
would reduce the impact of volition on the test’s validity,
and potentially may portray a more clinically relevant
picture of the patients’ abilities. A number of different
functional measures are currently under development.
The Physical Function ICU Test (PFIT) was developed
in Australia, in a tertiary referral center for long-term
tracheostomy patients [12]. This was later modified into
the PFIT-score (PFIT-s) using RASCH analysis and tested
in an acute ICU. Psychometrically, the PFIT-s has demon-
strated validity in the critical care population; however,
the large floor and ceiling effects on the ICU may limit
utility [13].
The University of Rochester Acute Care Evaluation
(URACE) [14] and the Functional Status Score for In-
tensive Care (FSS-ICU) [15] are both functional scoring
systems from North America in the early stages of devel-
opment. Both are potentially useful; however, they are
very much in their infancy, and further psychometric
evaluation is essential.
In March 2009, development began of the Chelsea
Critical Care Physical Assessment tool (CPAx), which is a
numeric and pictorial composite of 10 commonly assessed
components of physical function graded on a 6-point
Guttman Scale, from complete dependence to independ-
ence (0 to 5). The component scores are added to give
an overall score out of 50; 0 being the most-dependent
patient, and 50 representing full independence. The
score is also plotted on a “radar” chart, giving a rapid
pictorial impression of patients’ functions and highlighting
problem areas (Figure 1).The CPAx was developed by using classic test theory
through an iterative process including content-validity
questionnaires, an expert focus group, service-user feed-
back, and an extensive pilot study on a cohort of 33 ICU
patients [16]. This allowed proof of concept to be estab-
lished through convergent validation and basic interrater
reliability testing, which in turn provided a cogent argu-
ment for investigating the CPAx further. A copy of the
CPAx tool can be found in Additional file 1.
The aim of this study was to explore further the con-
struct validity of the CPAx by analyzing the association
between CPAx scores on ICU discharge and hospital-
discharge location. If the CPAx is to display construct
validity, then higher CPAx scores at ICU discharge should
be associated with better functional outcome in terms
of rehabilitation/care needs at hospital discharge, crudely
defined by discharge location.
Secondary aims were to analyze the usability of the
CPAx at the test center, through compliance with comple-
tion of CPAx scores; to analyze floor and ceiling effects of
the CPAx in the ICU; and to explore future level-of-care
needs in critical care survivors.
Methods
Data were collected from an 11-bedded general (mixed
medical-surgical, levels 2 and 3) ICU in central London
over a 42-month time period from 10 May 2010 to 13
November 2013. The physiotherapy service adopts a model
of daily review during which the physiotherapists’ role
includes both respiratory and physical therapy (that is,
exercise and functional rehabilitation).
The CPAx was developed at this center and embedded
into clinical practice as part of quality-improvement
initiative to improve compliance with the comprehensive
clinical-assessment component of the NICE guidelines for
Rehabilitation after Critical Illness [17]. Hence this project
was categorized as service evaluation by the local Research
and Development Department and the National Research
Ethics Service, and was considered exempt from the need
for specific research ethics review. No patient consent was
required for this study, as all data were anonymous and
routinely collected.
All physiotherapists were taught how to use the CPAx
tool by the primary developer (EC) in a case-based tutor-
ial. The CPAx has previously been shown to have good
interrater reliability, so no further testing was completed
as part of this study [16]. After training, the CPAx was
integrated into clinical practice, through an iterative
process of plan do study act (PDSA) cycles, adopted
from service-improvement methods. Compliance with
completion of the score was monitored regularly as
the percentage of all patients admitted with a com-
pleted CPAx score. When compliance was low and/or
Figure 1 Example of the CPAx radar chart. This image demonstrates that this patient’s respiratory function, cough, and bed mobility are
strong, and his rehabilitation should be tailored to work on gait reeducation, and on transferring from bed to chair, and from sit to stand.
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until use of the CPAx score was embedded into clinical
practice.
The clinical aim was for all patients staying in the ICU
for more than 48 hours to be scored throughout their
stay by using the CPAx at least 3 times per week, unless
there was a reason for exemption (for example, they did
not require physiotherapy input). The ICU physiothera-
pists collated the patients’ last CPAx scores taken within
24 hours of step down from ICU or death. The ward-
based physiotherapist or occupational therapist then
recorded the patients’ discharge location as part of theirTable 1 Hospital-discharge categories
Survival categories 1. Home with no rehabilitation needs, consid
the optimal outcome
2. Home with community support, this may
a full package of care to outpatient physioth
3. A short-stay inpatient-rehabilitation facility
4. A long-stay rehabilitation facility (>6 week
5. Nursing-home level of care
Nonsurvival categories 1. Nonsurvival from ICU
2. Nonsurvival from hospitaldischarge-planning process. The discharge locations were
separated into five survival categories in a hierarchic
manner, and two nonsurvival categories, listed in Table 1.
The ward and ICU physiotherapist were asked not to
discuss the CPAx scores of the patient on ICU discharge;
however, no formal measures were taken to guarantee
blinding of responsible medical or surgical multidiscip-
linary teams. It is unlikely, however, that the CPAx score
would have influenced the patients’ final discharge loca-
tions, as this would have been based on clinical need in
absence of prognostic evidence of the CPAx tool at the
time of the study.ered No community services accessed
vary from
erapy
Package of care
Integrated care team
Domiciliary therapy
Outpatient therapy
(<6 weeks) An inpatient facility that had a maximum length
of stay of 6 weeks.
s) An inpatient facility that had an expected length
of stay of more than 6 weeks.
Ongoing daily nursing needs in a nursing home
environment or home with a maximal-care package,
including a hospital bed and hoist transfers.
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criteria: ICU stay < less than 48 hours; no recorded
CPAx score within 24 hours of discharge from ICU;
discharge location unclear.
Statistical analysis
Statistical analysis was performed with Excel (version
2010; Microsoft Corporation, Seattle, WA, USA) and Prism
(version 5; GraphPad Software, San Diego, CA, USA). Data
were assessed for normality by using the D’Agostino
and Pearson omnibus normality test and are presented
as mean (±standard deviation) or median (interquartile
range); parametric or non-parametric equivalent tests
were used as appropriate. As the CPAx is an ordinal
scale, medians (interquartile ranges) of the CPAx score
are reported. Statistical differences between discharge
locations were assessed by analysis of variance (Kruskal-
Wallace), Dunn multiple comparison test was used to
analyze the individual differences between groups post
hoc. The primary level of significance was set at P < 0.05
adjusted for multiple comparisons.
Results
From 10 May 2010 to 13 November 2013, 1,524 patients
were admitted to the ICU. Demographic data of all 1,524
patients are reported in Table 2.
Of the 1,524 patients admitted during this period, 836
patients met the exclusion criteria. Final data are reported
for 499 patients. Demographic data for the 499 patientsTable 2 Demographic data for all patients admitted
during the study period (n = 1,524): data are presented
as number (percentage) and mean (SD) or median (IQR)
Age in years 58 (19.1)
Male 773 (50.6%)
Female 751 (49.2%)
Number receiving mechanical ventilation 691 (45.3%)
Mean ICU length of stay in days 6.8 (12.9)
Median ICU length of stay in days 2.6 (1–7.1)
Mean hospital length of stay in days 31.8 (77.7)
Median hospital length of stay in days 14 (6–30)
Survival at ICU discharge 1,331 (87.2%)
Mortality in ICU 188 (12.3%)
Median admission APACHE II 15 (10–20)
Referring specialty
Surgery 673 (44.1%)
Obstetrics and gynecology 88 (5.8%)
Medicine 485 (31.8%)
HIV/GUM 48 (3.1%)
Interhospital critical care transfer 94 (6.2%)
Other 139 (9.1%)included in the analysis are reported in Table 3, with sub-
group demographics for patients separated by discharge
location. Attrition information is displayed as a consort
diagram in Figure 2.
These data were normally distributed in the short-stay
and long-stay rehabilitation groups; in the remaining five
groups, data were skewed, so all data were treated as
nonparametric.
Construct validity
The median and interquartile range of CPAx scores for
patients when grouped by discharge location is summarized
in Figure 3.
Analysis of variance showed statistically significant dif-
ferences in the median CPAx scores between the seven
discharge groups (H (2) = 311.4, P < 0.0001). Post hoc ana-
lysis of the difference in median CPAx score between each
individual discharge group is reported in Table 4.
Usability
During the study period, the CPAx score was calculated
a total of 6,309 times with an average of 7.5 CPAx scores
per patient. Our target was a minimum of three CPAx
assessments per patient, per week. The average ICU
length of stay for our cohort was 11.54 days, so ideally,
patients would have had a CPAx score equated at least 5
times; hence the target number of CPAx assessments
was exceeded.
In the initial stages of introducing the CPAx tool into
clinical practice, compliance with completion of the
CPAx was quite low; quarterly percentage compliance
data are presented in Figure 4. Compliance is defined
as the percentage of all ICU admissions with a completed
CPAx score on a quarterly basis.
A number of PDSA cycles were completed to look at
implementation strategies to improve compliance rates.
This included training physiotherapists to use the CPAx
effectively, and altering the method of data recording. Data-
recording strategies began with a paper-based system,
which yielded compliance rates averaging at around 10%
from May 2010 to August 2010. The CPAx was then inte-
grated onto the ICU observation charts, increasing aver-
age compliance to around 25% from September 2010 to
April 2011. Finally, the CPAx was added to the local com-
puterized notes system with a forcing function to ensure
completion of the CPAx unless it was not clinically indi-
cated; in this case, a password was entered after discussion
with a senior physiotherapist. This improved compliance
rates dramatically, with a consistent compliance since June
2011 until now, averaging 78% of all ICU admissions.
Floor and ceiling effect
Four patients of 499 (0.8%) scored full marks of 50/50
on the CPAx score. These were all in the “home with no
Table 3 Demographic-subgroup analysis for each discharge category and the study population
Whole
population
Home with
no rehab needs
Home with
community support
Short-stay rehabilitation
facility (<6 weeks)
Long-stay rehabilitation
facility (>6 weeks)
Nursing home
level of care
Nonsurvival
from ICU
Nonsurvival
from hospital
N [%] 499 171 [34.3%] 131 [26.3%] 28 [5.6%] 25 [5.0%] 27 [5.4%] 80 [16.0%] 37 [7.4%]
Age (mean (SD)) 62.3 [18.31] 56.2 [17.41] 63.4 [18.33] 72.5 [12.1] 56.0 [15.8] 56.6 [24.56] 68.4 [16.37] 72 [14.04]
APACHE II (median (IQR)) 16 [10–20] 14 [11-18] 16 [13–21] 17 [13–20] 17 [11–20] 17 [16–24] 22 [18–24] 18 [16–22]
Mean ICU length of stay (SD) 11.54 [16.18] 6.44 [5.48] 11.27 [12.86] 21.7 [26.6] 33.28 [41.6] 15.0 [17.5] 13.0 [12.3] 8.74 [7.8]
Median ICU length of stay (days (IQR)) 6 [4-12] 4.5 [3-8] 6.8 [3-14] 9 [4–31] 14.2 [9–43] 7.1 [5–19] 9.3 [4-15] 5.9 [4-11]
Diagnosis (n (1%))
- Cardiac arrest 19 [3.8%] 1 [0.6%] 5 [3.8%] 0 0 2 [7.4%] 10 [12.5%] 1 [2.7%]
- Chronic cardiovascular disease 21 [4.2%] 2 [1.2%] 11 [8.4%] 3 [10.7%] 1 [4%] 2 [7.4%] 0 2 [7.4%]
- Cardiovascular dysfunction 19 [3.8%] 7 [4.1%] 4 [3.1%] 3 [10.7%] 0 1 [3.7%] 4 [5%] 0
- Cardiovascular monitoring 9 [1.8%] 4 [2.3%] 2 [1.5%] 0 0 0 1 [1,3%] 2 [7.4%]
- Diabetic ketoacidosis 3 [0.6%] 3 [1.8%] 0 [0%] 0 0 0 0 0
- Gastrointestinal dysfunction 67 [13.4%] 25 [14.6%] 20 [12.3%] 4 [14.3%] 1 [4%] 3 [11.1%] 8 [10%] 6 [22.2%]
- Gastrointestinal surgery 38 [7.6%] 18 [10.5%] 12 [9.2%] 2 [7.1%] 0 2 [7.4%] 4 [5%] 0
- Metabolic/Renal system dysfunction 39 [7.8%] 11 [6.4%] 11 [8.4%] 6 [21.4%] 3 [12%] 0 6 [7.5%] 2 [7.4%]
- Neurological system dysfunction 30 [6.0%] 5 [2.3%] 8 [6.1%] 1 [3.6%] 4 [16%] 3 [11.1%] 6 [7.5%] 3 [11.1%]
- Poisoning 4 [0.8%] 4 [2.3%] 0 0 0 0 0 0
- Hemorrhage 11 [2.2%] 7 [4.1%] 0 0 0 0 1[1.3%] 3 [11.1%]
- Respiratory system dysfunction 148 [29.7%] 54 [32%] 37 [28.3%] 6 [21.4%] 5 [20%] 9 [33.3%] 24 [30%] 13 [48.1%]
- Sepsis 70 [14.0%] 25 [14.6%] 16 [12.2%] 2 [7.1%] 7 [28%] 1 [3.7%] 14 [17.5%] 5 [18.5%]
- Trauma 10 [2.0%] 0 3 [2.3%] 1 [3.6%] 2 [8%] 4 [14.8%] 0 [0%] 0
- Other 11 [2.2%] 5 [2.9%] 2 [1.5%] 0 2 [8%] 0 2 [2.5%] 0
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1,524 patients admitted to 
the ICU (level 1 & 2) 
between 10/05/2010 and 
13/11/2013
811 had an ICU stay of 
less than 48 hours
84 patients had no CPAx 
score within 24 hours of 
discharge from ICU
24 patients were 
transferred to another 
hospital for acute care
12 patients had an 
unclear discharge 
destination
94 patients lost due to 
compliance with 
completion of the CPAx 
score 
n=499
Figure 2 Consort diagram.
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the lowest possible score of 0/50 on the CPAx score.
All of these patients died within 24 hours of this score
being recorded.
Future care needs
Of the 499 patients, 171 (34.3%) returned home with
no ongoing rehabilitation/care input. The remaining
210 (42.3%) survivors all required some form of on-
going rehabilitation or care: 131 (26.2%) required com-
munity support; 28 (5.6%) went to inpatient rehabilitation
for 6 weeks or less; and 25 (5.0%) went to inpatient0
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Figure 3 Box-and-whisker diagram demonstrating the median CPAx srehabilitation for more than 6 weeks; 27 (5.4%) required
nursing-home level of care. For the nonsurvival groups,
80 (16.0%) died in the ICU, and 37 (7.4%) died before
hospital discharge.
Discussion
Construct validity is a method of validation frequently
used in the absence of a gold-standard comparator and/
or when measuring a construct that is difficult to observe
[6]. It involves the development of hypotheses that a new
scoring system or questionnaire will behave as expected
in a specified population. For example, one would expect
patients in a persistent vegetative state to have a lower
Glasgow Coma Scale (GCS) score than patients in a
general medical ward.
Although the difference in average CPAx score between
groups did not reach statistical significance for all discharge
categories, these data show clear associations between
CPAx score at ICU discharge and final hospital-discharge
locations. In the survival groups, those that went home
with no rehabilitation input, which would be considered
the optimal outcome, scored the highest on the CPAx
score; and those requiring nursing-home level of care,
arguably the poorest survival outcome, scored the lowest.
This supports the hypothesis that the CPAx score at
final assessment within critical care is associated with
long-term recovery and rehabilitation trajectory, and thus
has construct validity. Taken together with the previous
validation work [16], it would seem reasonable to assume
that the CPAx may have a role in the assessment, descrip-
tion, and monitoring of functional recovery in patients
with ICU-AW.
On post hoc analysis, the individual differences between
groups reached significance in only 12 of the 21 compari-
sons, with those returning home with no rehabilitation
needs scoring significantly more than all other groups.
The numbers available for detailed intergroup comparisonsng term
bilitation
n=25)
Nursing home
level of care
(n=27)
Non-survival
from ICU
(n=80)
Non survival
from hospital
(n=37)
core for patients divided by discharge location (n = 498).
Table 4 Post hoc analysis of between-group differences
Home with no
rehabilitation needs
Home with
community
support
Short-stay
rehabilitation
(<6 weeks)
Long-stay
rehabilitation
(>6 weeks)
Nursing-home
level of care
Nonsurvival
from ICU
Home with community support P < 0.05
Short-stay rehabilitation (<6 weeks) P < 0.05 ns
Long-stay rehabilitation (>6 weeks) P < 0.05 P < 0.05 ns
Nursing-home level of care P < 0.05 P < 0.05 ns ns
Nonsurvival from ICU P < 0.05 P < 0.05 P < 0.05 P < 0.05 ns
Nonsurvival from hospital P < 0.05 ns ns ns ns P < 0.05
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ever, we would contend that the trends demonstrated in
Figure 3 support the construct validity of the CPAx tool as
a measure associated with future recovery trajectory. The
individual variation of recovery trajectory is substantial,
so it would not be appropriate to use the ICU discharge
CPAx score as an individual predictor of specific future
destination, but may be a crude indicator of whether a
patient is likely to need ongoing rehabilitation.
The variability in the CPAx scores for each discharge-
location group might be explained by a number of factors:
the heterogeneity of critical care patients; the level of
perceived “rehabilitation potential”; the baseline level of
function; and crucially, the level of family support and
home setup available to the patient. For example, the
patients that were discharged home with community
support had the widest range of CPAx scores. Clinically
this seems logical, as a large variation in the level of
support can be provided in a home environment. This
may vary from a large package of care for an elderly
and frail patient, to an outpatient physiotherapy service
for the more mobile.
Those discharged to a rehabilitation facility will be
admitted only if they are perceived to have rehabilitation
potential (that is, the ability to progress from their current
functional level. Those considered to have reached their
full potential are more likely to be discharged to a facility0%
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Figure 4 The percentage of all patients admitted to ICU with a comp
November 2013.with appropriate support (for example, a nursing home or
home in a modified environment with a package of care).
This may explain the narrower range of CPAx scores for
these groups.
Of note, the final location for discharge populations is
likely to be directly related to the facilities available in
local communities; hence, generalizing these data to other
geographic locations should be done with extreme caution.
For the nonsurvival group, those that died in the ICU
had the lowest CPAx score at their last assessment. Those
that later went on to die in the ward scored surprisingly
high on the CPAx score at ICU discharge. Subsequent
analysis revealed that the average age and APACHE II
scores for this group were at 72 and 18, respectively,
and many of these patients died of unforeseen medical
emergencies or were given palliation.
On subgroup analysis, there also appears to be an as-
sociation between age, ICU length of stay, and APACHE
II scores, with discharge location. As might be expected,
those that return home with no ongoing rehabilitation
were younger (mean, 56.2 years), had a shorter ICU length
of stay (mean days (SD), 16.18) and lower APACHE II
scores (median (IQR): 14 (11–18)). Those that went home
with community support tended to be a little older than
the first group (mean age, 63.4 years), sicker (APACHE II
median (IQR): 16 (13–21), and had a longer mean length
of stay (days (SD): 11.27 (12.86)); and this trend continues11
/1
1
01
/1
2
03
/1
2
05
/1
2
07
/1
2
09
/1
2
11
/1
2
01
/1
3
03
/1
3
05
/1
3
07
/1
3
ter beginning
leted CPAx score on a quarterly basis between May 2010 and
Corner et al. Critical Care 2014, 18:R55 Page 8 of 10
http://ccforum.com/content/18/2/R55until the long-stay rehabilitation and nursing-home level-
of-care categories, who included two of the youngest
groups, averaging 56 years (SD, 15.8) and 56.6 years
(SD, 24.56), respectively. Of note, these categories also
had the highest proportion of neurology patients, which
may help to explain the younger age bracket.
Furthermore, long-term rehabilitation facilities are sparse,
so their admission criteria tend to be more specific, often
favoring those considered to have more rehabilitation
potential, which may be associated with a younger cohort.
Those discharged to a nursing-home facility had one of
the highest average APACHE II scores (median (IQR): 17
(16 to 24]); it is possible that older patients with significant
functional limitation requiring long-term nursing care are
less likely to survive until hospital discharge, so there may
be an element of natural selection for the younger patient
within this category. Furthermore, these findings may be
associated with admission criteria to the ICU and previous
functional level.
A number of other authors have published work on
new scoring systems to measure function in critical care,
of which the Physical Functional Test for use in the ICU-s
(PFIT-s) has been through the most stringent psycho-
metric analysis, demonstrating convergent, discriminant,
and predictive validity. This testing also included Rasch
analysis, allowing conversion of the score from an ordinal
to an interval scale [13].
The PFIT-s combines assessment of shoulder and knee
strength graded on the Oxford scale with cadence (steps/
minute) and level of assistance. The content of this score
is very different from the functional components in the
CPAx score, focusing more on strength, endurance, and
exercise capacity, than on function. This, and the vol-
itional nature of the PFIT-s, may explain the 21.5% floor
and 22.2% ceiling effect on critical care: an important
limitation in its clinical and research application [13].
The floor and ceiling effect of the CPAx tool in the ICU is
minimal, with only four of 499 patients scoring full marks,
and 16 patients scoring 0; all of whom unfortunately died
in the next 24 hours, suggesting that the CPAx is likely to
be able to detect change throughout the spectrum of func-
tional level seen in the ICU and thus may be a more useful
measure at this time point. However, no scoring system
will ever span the spectrum from complete dependence to
full function; it may be more appropriate for a battery of
scores to be used at different time points throughout the
patient journey.
The Functional Status Score for ICU (FFS-ICU) is also
in development [15]. The FSS-ICU has more similarities
to the CPAx scale, in that it grades patients on a Guttman
scale from 1 to 7, dependent on their level of assistance
required, and it assesses five of the same functional tasks:
ambulation, rolling, sitting, supine to sitting, and sit-to-
stand transfers.The FSS-ICU has shown similar associations with hos-
pital discharge location as the CPAx in a smaller cohort
of 101 patients in North America, which is unsurprising,
given the similarities in the contents of the two tools.
Notably, the investigators also showed a wide range of
FSS-ICU scores for the five discharge categories that they
used: home; inpatient-rehabilitation facility; skilled-nursing
facility; hospice/long-term care; and transfer to short-stay
hospital [15]. Although key differences in practice exist
between North America and Europe, making difficult a
direct comparison between results, this wide range of
CPAx and FSS-ICU scores for each discharge group
supports the suggestion that accurate prediction of
hospital-discharge location is likely to be difficult. This is
probably due to its interdependency on so many other
factors (for example, social setup and support and pre-
morbid functional level).
The concurrent but independent development of the
CPAx and the FFS-ICU in different continents is support-
ive of the face and content validity of the basic common
concepts behind both measures. Importantly, the differ-
ences between the two tools, the respiratory and cough
components of the CPAx, probably reflect the difference
in physiotherapy versus physical therapy practice between
Europe and Australasia, and North America. In Europe
and Australasia, the role of the respiratory therapist and
physical therapist practiced in North America is merged
into one. As physiotherapists have a key role in weaning
from mechanical ventilation and airway clearance, the in-
clusion of the cough and respiratory-function components
in the CPAx, and the exclusion of these components in
the FFS-ICU, may indicate that each score is more suited
to the professional environment in which they were devel-
oped. As respiratory muscle strength is closely associated
with peripheral muscle strength and thus function, it is
important that this be considered in a measurement scale
designed for weaning patients.
These service-evaluation data have demonstrated that
the CPAx can be implemented in a sustainable manner,
with consistently around 78% of all ICU admissions re-
ceiving a comprehensive clinical assessment on the CPAx
tool once established. Any patients not scored by using
the CPAx will have been assessed for suitability by a senior
clinician and actively excluded. The most common reason
for this was that the patient was not requiring, or thus
receiving any physiotherapy intervention; or because a full
assessment could not be completed (for example, because
they were receiving a medical intervention or declined
assessment). The time taken to complete the CPAx score
has not been formally evaluated; however, it is estimated
from staff feedback to take an average of around 2 minutes;
this is primarily because it was designed to allow a num-
ber to be attributed to what would be considered a stand-
ard physiotherapy assessment in the UK, suggesting that it
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nent of the CPAx assessment is the only additional item
to standard ICU physiotherapy assessments.
Importantly, these data also illustrate the impact that
critical illness has had on our local community health
services over the past 3-year period. An alarming 210
patients of the 499 in this population who were discharged
alive required ongoing support and rehabilitation, demon-
strating how ICU-AW is a public health issue that extends
well beyond the walls of the ICU [5].
Limitations
This was a service evaluation completed at one center in
a predominantly affluent area of London. This may have
had an impact on the case mix, although the demographic
and diagnostic data look reasonably typical for a mixed
UK critical care population [18]. There was no blinding
of the physiotherapists making the clinical decisions
about discharge location to the patients’ CPAx scores.
It is unlikely that this would have influenced the discharge
location, as discharge destination would be based on
clinical need, and reliance on the CPAx score as a guide
may have been unsafe.
Some missing data, and variable compliance with com-
pletion of the scores, were found predominantly from
the early phases; the impact of this on the final results is
likely to be small in a cohort of 499. Although only CPAx
scores within 24 hours of ICU discharge were included,
some CPAx scores were taken while the patient was still
intubated; hence the validity of those specific scores as a
reflection of the patients’ true function at ICU discharge
may be questioned; if these scores had been excluded, it is
likely to have narrowed the spread of data. Discharge from
ICU is a loose outcome time point, as it is dependent
on a number of factors (for example, bed availability
and ward staffing).
The post hoc analysis of differences in average CPAx
scores between groups did not reach statistical signifi-
cance for all categories, which may limit the validity of
the results; however, this is tempered by the clear associ-
ation between CPAx scores and discharge location, the
likeness of these data to clinical practice, and the crudity
of discharge location as a measure of outcome.
With regard to implementation, it should be noted that
this report describes the experience of implementation in
the hospital in which the tool was developed and thus had
strong local champions. However, the CPAx has now been
sent out for adoption at 86 other institutions, many of
which have, in their view, successfully embedded its use
within practice.
Conclusions
The data presented would support the contention that
the CPAx has construct validity, and taken with previouslypublished validation work, it would now seem reasonable
to use this in practice, with the caveat that its performance
requires continuing evaluation.
The CPAx score has shown strong associations with
hospital-discharge location, as a surrogate for functional
outcome; can be embedded into clinical practice sustain-
ably; and it has a limited floor and ceiling effect on the
ICU. Integration of the CPAx into clinical practice may
help professionals to monitor and describe functional
recovery from critical illness in a more objective manner,
thus opening up communication between professionals
and service users about patients’ functional recovery, or
lack thereof.
Further studies are essential to investigate whether the
CPAx will help to identify areas of rehabilitation need,
thus assisting in physiotherapy assessment, treatment
planning, and goal setting; further analysis of training
and implementation; and whether the CPAx has sufficient
psychometric properties to be used as a standardized out-
come assessment in clinical practice and interventional
research.
This work also demonstrates that the level of ongoing
rehabilitation need in critical care survivors is substantial,
illustrating just how catastrophic critical illness can be.
Key messages
 The CPAx score can be embedded into clinical
practice sustainably.
 The CPAx score shows strong associations with
hospital-discharge location as surrogate for functional
outcome, implying construct validity.
 The CPAx has a limited floor-and-ceiling effect on
the ICU, also implying validity.
 The level of ongoing rehabilitation need in critical
care patients’ survivors is substantial, illustrating just
how catastrophic critical illness can be.
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